TrialInternational journal of radiation oncology, biology, physics2023

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.

Aditya Juloori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.